Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing Technology
Portfolio Pulse from
Compugen Ltd. has enhanced its AI/ML predictive computational discovery platform, Unigen™, by integrating Ultima Genomics' single-cell genomics sequencing technology. This collaboration aims to improve understanding of tumor biology and immune regulation.
February 26, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Compugen Ltd. has integrated Ultima Genomics' sequencing technology into its Unigen™ platform, potentially enhancing its capabilities in tumor biology and immune regulation research.
The integration of Ultima Genomics' technology into Compugen's platform is likely to enhance its research capabilities, which could lead to advancements in understanding tumor biology and immune regulation. This development is significant for Compugen's growth and innovation in the biotech sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90